NovelStem International Corp. (NSTM)
USD 0.01
(23.46%)
USD 0.01
(23.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - USD | 100.0% |
| 2022 | -65.79 Million USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 3.73 Million USD | -16.83% |
| 2008 | 4.49 Million USD | 13.7% |
| 2007 | 3.95 Million USD | 17.08% |
| 2006 | 3.37 Million USD | -75.07% |
| 2005 | 13.53 Million USD | 59.85% |
| 2004 | 8.46 Million USD | 46.74% |
| 2003 | 5.77 Million USD | -19.23% |
| 2002 | 7.14 Million USD | 0.82% |
| 2001 | 7.08 Million USD | 6541.47% |
| 2000 | 106.7 Thousand USD | -91.11% |
| 1999 | 1.2 Million USD | 0.0% |
| 1998 | 1.2 Million USD | -50.0% |
| 1997 | 2.4 Million USD | 71.43% |
| 1996 | 1.4 Million USD | 133.33% |
| 1995 | 600 Thousand USD | 100.0% |
| 1994 | 300 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2023 FY | - USD | 100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 100.0% |
| 2023 Q2 | -26.49 Thousand USD | 0.0% |
| 2022 Q3 | -130.37 Thousand USD | 0.0% |
| 2022 Q4 | -65.79 Million USD | -50361.68% |
| 2022 FY | -65.79 Million USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | 6.27 Million USD | 110.9% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 5.24 Million USD | -16.44% |
| 2010 Q1 | 2.97 Million USD | -20.34% |
| 2010 FY | - USD | -100.0% |
| 2009 Q4 | 3.73 Million USD | -8.24% |
| 2009 Q1 | 4.57 Million USD | 1.92% |
| 2009 FY | 3.73 Million USD | -16.83% |
| 2009 Q2 | 5.85 Million USD | 27.93% |
| 2009 Q3 | 4.07 Million USD | -30.48% |
| 2008 Q1 | 4.22 Million USD | 6.97% |
| 2008 FY | 4.49 Million USD | 13.7% |
| 2008 Q3 | 7.81 Million USD | 66.03% |
| 2008 Q2 | 4.7 Million USD | 11.32% |
| 2008 Q4 | 4.49 Million USD | -42.49% |
| 2007 Q1 | 5.87 Million USD | 74.26% |
| 2007 FY | 3.95 Million USD | 17.08% |
| 2007 Q4 | 3.95 Million USD | -41.72% |
| 2007 Q3 | 6.77 Million USD | 15.89% |
| 2007 Q2 | 5.84 Million USD | -0.53% |
| 2006 Q2 | 4.58 Million USD | 45.84% |
| 2006 Q4 | 3.37 Million USD | -7.35% |
| 2006 FY | 3.37 Million USD | -75.07% |
| 2006 Q3 | 3.64 Million USD | -20.5% |
| 2006 Q1 | 3.14 Million USD | -76.79% |
| 2005 Q4 | 13.53 Million USD | 2.52% |
| 2005 Q3 | 13.2 Million USD | 12.01% |
| 2005 Q2 | 11.78 Million USD | -9.11% |
| 2005 Q1 | 12.96 Million USD | 53.17% |
| 2005 FY | 13.53 Million USD | 59.85% |
| 2004 Q4 | 8.46 Million USD | 8.24% |
| 2004 FY | 8.46 Million USD | 46.74% |
| 2004 Q1 | 8.87 Million USD | 53.78% |
| 2004 Q2 | 6.61 Million USD | -25.4% |
| 2004 Q3 | 7.82 Million USD | 18.17% |
| 2003 Q2 | 6.17 Million USD | -28.58% |
| 2003 Q1 | 8.63 Million USD | 20.93% |
| 2003 FY | 5.77 Million USD | -19.23% |
| 2003 Q3 | 6.87 Million USD | 11.34% |
| 2003 Q4 | 5.77 Million USD | -16.01% |
| 2002 FY | 7.14 Million USD | 0.82% |
| 2002 Q3 | 7.8 Million USD | 17.43% |
| 2002 Q4 | 7.14 Million USD | -8.43% |
| 2002 Q2 | 6.64 Million USD | -25.6% |
| 2002 Q1 | 8.92 Million USD | 26.0% |
| 2001 Q1 | 728.12 Thousand USD | 582.4% |
| 2001 FY | 7.08 Million USD | 6541.47% |
| 2001 Q2 | 5.77 Million USD | 693.01% |
| 2001 Q4 | 7.08 Million USD | -2.18% |
| 2001 Q3 | 7.24 Million USD | 25.46% |
| 2000 Q3 | 1.31 Million USD | 5.34% |
| 2000 Q4 | 106.7 Thousand USD | -91.91% |
| 2000 Q2 | 1.25 Million USD | 9.33% |
| 2000 Q1 | 1.14 Million USD | -4.57% |
| 2000 FY | 106.7 Thousand USD | -91.11% |
| 1999 Q4 | 1.2 Million USD | 9.09% |
| 1999 Q3 | 1.1 Million USD | 0.0% |
| 1999 FY | 1.2 Million USD | 0.0% |
| 1999 Q1 | 900 Thousand USD | -25.0% |
| 1999 Q2 | 1.1 Million USD | 22.22% |
| 1998 Q2 | 1.7 Million USD | -19.05% |
| 1998 Q3 | 1.9 Million USD | 11.76% |
| 1998 Q4 | 1.2 Million USD | -36.84% |
| 1998 Q1 | 2.1 Million USD | -12.5% |
| 1998 FY | 1.2 Million USD | -50.0% |
| 1997 Q3 | 2 Million USD | 33.33% |
| 1997 FY | 2.4 Million USD | 71.43% |
| 1997 Q4 | 2.4 Million USD | 20.0% |
| 1997 Q1 | 1.5 Million USD | 7.14% |
| 1997 Q2 | 1.5 Million USD | 0.0% |
| 1996 Q4 | 1.4 Million USD | 40.0% |
| 1996 FY | 1.4 Million USD | 133.33% |
| 1996 Q1 | 700 Thousand USD | 16.67% |
| 1996 Q2 | 800 Thousand USD | 14.29% |
| 1996 Q3 | 1 Million USD | 25.0% |
| 1995 FY | 600 Thousand USD | 100.0% |
| 1995 Q3 | 400 Thousand USD | 0.0% |
| 1995 Q4 | 600 Thousand USD | 50.0% |
| 1994 Q4 | 300 Thousand USD | 200.0% |
| 1994 FY | 300 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 100.0% |
| Arrayit Corporation | 464.19 Thousand USD | 100.0% |
| Atlantic International Corp. | - USD | NaN% |
| Biocept, Inc. | 757 Thousand USD | 100.0% |
| Bioqual, Inc. | - USD | NaN% |
| CardioGenics Holdings Inc | -2385.00 USD | 100.0% |
| DermTech, Inc. | 1 Million USD | 100.0% |
| Global WholeHealth Partners Corporation | - USD | NaN% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 100.0% |
| iMD Companies, Inc. | 38.31 Thousand USD | 100.0% |
| IDenta Corp. | 442.28 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | - USD | NaN% |
| InVitro International | 163.13 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 100.0% |
| Medical Imaging Corp. | - USD | NaN% |
| Optigenex Inc. | 468.77 Thousand USD | 100.0% |
| PharmChem, Inc. | 391.93 Thousand USD | 100.0% |
| Proteome Sciences plc | 1.06 Million USD | 100.0% |
| Response Genetics, Inc | 133 Thousand USD | 100.0% |
| Rennova Health, Inc. | 242.64 Thousand USD | 100.0% |
| RushNet, Inc. | - USD | NaN% |
| ScreenPro Security Inc. | 73.89 Thousand USD | 100.0% |
| Stella Diagnostics Inc. | - USD | NaN% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | 100.0% |
| Todos Medical Ltd. | 1.02 Million USD | 100.0% |